Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission on Combination Therapy: A Randomized, Double‐Blind Trial

In this study, adults in remission on methotrexate (MTX) plus etanercept (ET) over 24 weeks were randomised to continue this, or to receive MTX or ET monotherapy. Maintenance of remission was higher with MTX withdrawal than ET withdrawal (49.5% v 28.7%; p=0.004).

Source:

Arthritis & Rheumatology